Castle Biosciences
$34.20
49
+$1.27+3.86% 20:00 Today
-$1.22-3.55%21:12After hours
Statistics
Day High
34.7
Day Low
32.14
52W High
44.28
52W Low
17.72
Volume
573,465
Avg. Volume
400,680
Mkt Cap
1.04B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
9NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.9
-0.49
-0.09
0.32
Expected EPS
-0.357778
Actual EPS
N/A
Financials
-7.02%Profit Margin
Unprofitable344.23MRevenue
-24.16MNet Income
Analyst Ratings
41.75Average Price Target
The highest estimate is 44.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CSTL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.1B
Myriad Genetics
MYGN
Mkt Cap289.82M
Fulgent Genetics
FLGT
Mkt Cap510.68M
Qiagen NV
QGEN
Mkt Cap8.87B
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Illumina
ILMN
Mkt Cap28.82B
About
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Show more...
CEO
Derek J. Maetzold
Employees
1002
Country
United States
ISIN
US14843C1053
WKN
000A2PNH3
Listings
0 Comments
Share your thoughts
FAQ
What is Castle Biosciences stock price today?▼
The current price of CSTL is $34.20 USD — it has increased by +3.86% in the past 24 hours. Watch Castle Biosciences stock price performance more closely on the chart.
What is Castle Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Castle Biosciences stocks are traded under the ticker CSTL.
Is Castle Biosciences stock price growing?▼
CSTL stock has risen by +15.46% compared to the previous week, the month change is a +39.53% rise, over the last year Castle Biosciences has showed a +71.26% increase.
What is Castle Biosciences market cap?▼
Today Castle Biosciences has the market capitalization of 1.04B
When is the next Castle Biosciences earnings date?▼
Castle Biosciences is going to release the next earnings report on November 09, 2026.
What were Castle Biosciences earnings last quarter?▼
CSTL earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.41 USD resulting in a +82.8% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Castle Biosciences revenue for the last year?▼
Castle Biosciences revenue for the last year amounts to 344.23M USD.
What is Castle Biosciences net income for the last year?▼
CSTL net income for the last year is -24.16M USD.
How many employees does Castle Biosciences have?▼
As of August 21, 2026, the company has 1,002 employees.
In which sector is Castle Biosciences located?▼
Castle Biosciences operates in the Health & Wellness sector.
When did Castle Biosciences complete a stock split?▼
Castle Biosciences has not had any recent stock splits.
Where is Castle Biosciences headquartered?▼
Castle Biosciences is headquartered in FRIENDSWOOD, United States.